REBECCA DUNN: Open Payments
NPI 1659509974 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,258 in 54 payments from 14 companies in 2025. Trend: 2023 $497 · 2024 $924 · 2025 $1,258
Food & beverage: $1,124Education: $134
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $293 |
| Janssen Biotech, Inc. | 5 | $201 |
| Novartis Pharmaceuticals Corporation | 6 | $168 |
| PFIZER INC. | 9 | $142 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $94 |
| Biofrontera Inc. | 4 | $85 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $72 |
| Galderma Laboratories, L.P. | 2 | $46 |
| Organon LLC | 4 | $39 |
| LEO Pharma Inc. | 1 | $34 |
Products named: SKYRIZI, TREMFYA, SPEVIGO, CIBINQO, ILUMYA, COSENTYX, AMELUZ, LITFULO.
Industry payments across UT — which companies pay providers there.
